Skip to main content

Holiday schedule

Quest Diagnostics Patient Service Centers will have modified hours during the holiday season.

  • Closing early at 12:00pm on December 24, 2025
  • Closed on December 25, 2025
  • Closing early at 12:00pm on December 31, 2025
  • Closed on January 1, 2026


Have a healthy, happy holiday!

Hide
Quest Diagnostics

IL-1 Receptor 1 Signaling Shapes the Development of Viral Antigen-Specific CD4+ T Cell Responses Following COVID-19 mRNA Vaccination

IL-1 Receptor 1 Signaling Shapes the Development of Viral Antigen-Specific CD4+ T Cell Responses Following COVID-19 mRNA Vaccination

Authors: Park HJ, Shin MS, Shin JJ, Kim H, Kang B, Par-Young J, Unlu S, Afinogenova Y, Catanzaro J, Young J, Kim M, Lee SJ, Jeon S, You S, Racke MK, Bucala R, Kang I

Citation: EBioMedicine. 2024 Apr 18;103:105114. doi: 10.1016/j.ebiom.2024.105114. Online ahead of print.

Specialties: Infectious disease, COVID-19, Immunology

Related content

Publication
Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection
Publication
Assessing vulnerability to COVID 19 in high risk populations: the role of SARS CoV 2 spike targeted serology
Publication
SARS-CoV-2 Spike-Protein Targeted Serology Test Results and Their Association With Subsequent COVID-19-Related Outcomes
Publication
Prior cycles of anti-CD20 antibodies affect antibody responses after repeated SARS-CoV-2 mRNA vaccination
Publication
Microfluidic immuno-serolomic assay reveals systems level association with COVID-19 pathology and vaccine protection
Publication
Comparison of SARS-CoV-2 RT-PCR Ct values across multiple assays with different targets
Publication
New diagnosis of systemic lupus erythematosus after COVID-19 vaccination: A case report and review of literature

Related content

Conference Presentation
SARS-CoV-2 mRNA Vaccination Affects Antibody and Cellular Immune Responses After B-Cell Depletion Therapies
Publication
Defining Clinical and Immunological Predictors of Poor Immune Responses to COVID-19 mRNA Vaccines in Patients with Primary Antibody Deficiency
Conference Presentation
Correlates of immunity in SARS-CoV-2 post-vaccine infectious in the Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) Study
Publication
SARS-CoV-2 Spike-Protein Targeted Serology Test Results and Their Association With Subsequent COVID-19-Related Outcomes

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.